Product Recalls in South Carolina

Product recalls affecting South Carolina — including food, drugs, consumer products, medical devices, and vehicles distributed to South Carolina. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,723 recalls have been distributed to South Carolina in the last 12 months.

51,854 total recalls
2,723 in last 12 months

Showing 49614980 of 13,686 recalls

DrugJanuary 7, 2020· Preferred Pharmaceuticals, Inc

Recalled Item: Preferred Pharmaceuticals Recalled by Preferred Pharmaceuticals, Inc Due to...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 7, 2020· Preferred Pharmaceuticals, Inc

Recalled Item: Preferred Pharmaceuticals Recalled by Preferred Pharmaceuticals, Inc Due to...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 7, 2020· AVKARE Inc.

Recalled Item: Dutasteride Capsules Recalled by AVKARE Inc. Due to Failed...

The Issue: Failed Impurities/Degradation Specifications: High out of specification...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 6, 2020· H J Harkins Company Inc dba Pharma Pac

Recalled Item: Ranitidine Recalled by H J Harkins Company Inc dba Pharma Pac Due to CGMP...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 26, 2019· Akorn, Inc.

Recalled Item: Proparacaine Hydrochloride Ophthalmic Solution Recalled by Akorn, Inc. Due...

The Issue: Chemical contamination; out of specification results obtained for equipment...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 26, 2019· Lupin Pharmaceuticals Inc.

Recalled Item: Blisovi Fe 1.5/30 (norethindrone acetate and ethinyl estradiol tablets USP...

The Issue: Failed Tablet/Capsule Specifications: Complaints related to crumbling of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 23, 2019· GSK Consumer Health, Inc

Recalled Item: Theraflu Cough Relief Recalled by GSK Consumer Health, Inc Due to Labeling:...

The Issue: Labeling: Label Lacks Warning: Product recalled due to absence of a warning...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: BAC 160MCG/HYDROM 16MG/ML INJ in 20 mL syringe Assurance Infusion Recalled...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: HYDROM 1MG/MORP 20MG/SUF 100MCG/ML INJ in 20 mL syringe Assurance Recalled...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: BAC 2400MCG/ FENT 2600MCG/ MORP 3600MCG/ML INJ in 20 mL Recalled by...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Denton Pharma, Inc.

Recalled Item: Ranitidine Tablets Recalled by Denton Pharma, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Denton Pharma, Inc.

Recalled Item: Ranitidine Tablets Recalled by Denton Pharma, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: LIPO B 25MG/50MG/50MG/1000MCG/ML (10ML VIAL) in 20 mL syringe and Recalled...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: BUP 5.3MG/ FENT 1050 MCG/ML INJ in 20 mL syringe Recalled by Assurance...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: BUP 20MG/CLON 250MCG/FENT 7200MCG/ML INJ in 20 mL syringe Assurance Recalled...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Taro Pharmaceuticals U.S.A., Inc.

Recalled Item: Lamotrigine Tablets Recalled by Taro Pharmaceuticals U.S.A., Inc. Due to...

The Issue: Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: BUP 10MG/ FENT 1000MCG/ML INJ in 20 mL syringe Assurance Recalled by...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: HYDROMORPHONE 2MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: BUP 5MG/HYDROM 5MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: BUP 35MG/MORP 10MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund